An invited review in the New England Journal of Medicine stated it plainly: the positive cardiac and renal effects of GLP-1 receptor agonists are more than just improvement in ambient glucose concentrations, pointing to pleiotropic vascular actions as key contributors to the MACE reductions observed across LEADER, SUSTAIN-6, SELECT, and the other landmark trials
Do not change diabetes medicine doses on your own while waiting for new treatment options
However, stimulation of intestinal BTRs by administration of different BTR agonists directly into the stomach or duodenum, thereby bypassing oral perception, has not been reported to cause any adverse effects in preclinical models and healthy subjects
Ginger tea, bland foods, and anti-nausea medications (if prescribed) can help manage symptoms that interfere with adequate nutrition
Captulo 5: Mecanismo de Accin de los Anlogos de Receptores de GLP-1 en el Tratamiento de la Diabetes En el abordaje contemporneo de la diabetes, los anlogos de receptores de GLP-1 han emergido como herramientas teraputicas cruciales